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Summary (250) 
Recognition of pathogens and altered self must be efficient and highly specific to 
orchestrate appropriate responses while limiting excessive inflammation and autoimmune 
reaction to normal self. AIM2 is a member of innate immune sensors that detects the 
presence of DNA, arguably the most conserved molecules in living organisms. However 
AIM2 achieve specificity by detecting altered or misslocalized DNA molecules.  It can 
detect damaged DNA, and the aberrant presence of DNA within the cytosolic compartment 
such as genomic DNA released into the cytosol upon loss of nuclear envelope integrity. 
AIM2 is also a key sensor of pathogens that detects the presence of foreign DNA 
accumulating in the cytosol during the life cycle of intracellular pathogens including 
viruses, bacteria and parasites. AIM2 activation initiates the assembly of the 
inflammasome, an innate immune complex that leads to the activation of inflammatory 
caspases. This triggers the maturation and secretion of the cytokines IL-1β and IL-18. It 
can also initiate pyroptosis, a proinflammatory form of cell death.  
The AIM2 inflammasome contributes to physiological responses and diseases. It is a key 
player in host defenses, but its deregulation can contribute immune-linked diseases, such 
as autoinflammatory and autoimmune pathologies.  Moreover, AIM2 may play a role in 
cancer development.  
Recent studies have shown that the detection of self-DNA species by AIM2 is an important 
factor that contributes to diseases associated with perturbation of cellular homeostasis.  
Thus, in addition of being a sensor of pathogen associated molecular patterns (PAMPs), 
the AIM2 inflammasome is emerging as a key guardian of cellular integrity.  
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1 INTRODUCTION  
 
Pathogens as well as signals triggered by cellular perturbations engage innate immune 
programs. These responses use a set of germline-encoded pattern recognition receptors 
(PRRs) to limit the spreading of pathogens and restore tissue integrity and function. Each 
PRR functions by recognizing specific molecular signatures. If these signals originate from 
the microbial world they are referred to as pathogen-associated molecular patterns 
(PAMPs) or microbe-associated molecular patterns (MAMPs). If the PRRs detect self-
signatures, these signals are termed danger associated molecular patterns (DAMPs) or 
stress signals also known as alarmins (1). These stress signals can be generated by the loss 
of cellular integrity. The term homeostasis-altering molecular processes (HAMPs) has 
been proposed to define pro-inflammatory alterations of cellular homeostasis (2). Different 
types of PRR have evolved to detect a limited number of signatures. The best characterized 
are the Toll-like receptors (TLRs), the NOD-like receptors (NLRs), the C-type lectin 
receptor (CLRs), the RIG-I-like receptors (RLRs) and the AIM2-like receptors (ALRs). 
Although these different families differ in their overall structure, they converge on similar 
signal transduction cascades that eventually trigger the activation of pro-inflammatory 
transcription factors such as type I interferon and NF-kB. A group of NLRs and ALRs can 
form inflammasomes. These protein complexes form signaling platforms that harbor a 
proteolytic activity at their core. This enzymatic activity leads to the activation of 
pyroptosis-mediated cell death and/or the release of active IL-1b and IL-18. These two 
cytokines engage the transmembrane receptors IL-1R and IL-18R to promote inflammation 
via the activation of NF-kB transcriptional programs through the activation of MyD88 a 
key signaling adaptor in innate immunity (3).  
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The proinflammatory transcription factors such as type I IFN and NF-κB pathway regulate 
cytokines and chemokines production thereby promoting leukocyte recruitment. These 
factors also regulate feedback controls of inflammation orchestrating the magnitude and 
duration of immune responses. Deregulation of these signals can contribute to diseases by 
promoting uncontrolled inflammation. PRRs activation are often involved in the initial 
steps eliciting deregulated inflammation. Defining the mechanisms by which PRRs are 
activated and regulated is therefore a key step in understanding how deregulated 
inflammation is initiated in several conditions and diseases.  
Here we will review the biology of AIM2, an inflammasome-forming PRR. We will 
discuss its ability to detect both self and non-self DNA and how this pathway contributes 
to diseases.  
 
2. AIM2 DEFINES A NEW CLASS OF INNATE IMMUNE SENSORS  
2.1 AIM2 structural organization  
AIM2 and the ALRs are structurally defined by two main domains; the HIN domain and 
the pyrin domain (PYD). The HIN domain is present in one copy in AIM2, but some ALRs 
such as IFI16 harbors two HIN domains at the C-terminus. This domain has structural 
similarities to the oligonucleotide/oligosaccharide binding (OB)-folds (4). The OB fold 
consists of five or six-stranded b-barrel formed by 70-80 amino acid residues. The strands 
are connected by loops of varying length that form the ligand-binding region of the protein. 
OB fold can bind oligosaccharides, oligonucleotides, proteins and metal ions. Typically, 
OB folds are found in proteins that interact with single stranded DNA (ssDNA) such as 
BRCA2, a tumor suppressor involved in the repair of DNA damages, that binds ssDNA to 
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initiate homologous recombination. Based on amino-acid sequence similarities, the HIN 
domains within ALRs have been shown to recognize DNA and have been classified in 
three distinct sub-classes, HIN-A, HIN-B and HIN-C (5). It has been proposed that 
different subclasses may differ in function or may bind DNA with different affinities (6).  
The PYD domain that characterizes the N-terminus of the ALRs is a member of the death 
fold structures formed by six coiled alpha helices arranged in a "Greek-key" fold (7, 8). 
This fold is commonly found in proteins involved in apoptosis or inflammation and 
participates in protein–protein interactions leading to the formation of large signaling 
complexes. Death folds commonly bind to other death-fold containing domains of the same 
type through homotypic interactions. Therefore PYD domain proteins interact with other 
PYD domain proteins via highly specific PYD-PYD interactions. Upon activation, AIM2 
binds and recruits the adaptor protein apoptosis-associated speck-like protein containing a 
CARD (ASC) via PYD-PYD interactions (9-11). This interaction contributes to the initial 
steps of inflammasome assembly.  
 
2.2 The ALRs family has undergone recent and rapid evolution 
ALRs are exclusively present in placental mammals and marsupial genomes (12). 
Phylogenetic analyses have shown that mammalian ALRs have evolved considerably, 
leading to diversification of the repertoire (13). Except for AIM2 that is possibly the most 
conserved ALR, no evident orthology is detected between the thirteen predicted mouse and 
the four human ALRs. Other mammals such as cow have only one predicted ALR in the 
genome (12). Such a remarkable diversity among relatively close species has been 
observed for genes involved in innate immunity (14). This was noted for the NLRP family, 
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another group of PRR forming inflammasomes (15). It is likely that such diversity may 
reflect selective pressure placed on these genes by pathogens (16). While AIM2 appears to 
be able to recognize DNA molecules independently of the sequence, it is possible that other 
ALRs may detect specific sequences or modifications that would identify the pathogenic 
DNA encountered. This hypothesis could explain the selection pressure observed for ALRs 
family member and the relative conservation of AIM2. Analysis of AIM2 genome 
suggested that AIM2 expression is deficient in the genome of some mammals such as cow, 
sheep, dolphin, pig, cat and dog. This may indicate that through amplification and 
duplication processes other ALRs may have fulfilled AIM2 function in these mammals.  
Interestingly, analysis of over ten bat genomes revealed that all bats had lost the entire 
ALRs repertoire while other NLR innate immune sensors such as NLRP3 were conserved 
(17). The evolutionary events that specifically removed the ALRs genes from bats genomes 
are still unclear. Bats are the only mammals capable of flight. This process is very 
demanding on the metabolic machinery and may cause the accumulation of harmful 
metabolic byproducts that can affect cellular homeostasis and integrity. Inflammatory and 
repair pathways could be induced as a response to the release of these stress signals. Thus, 
it has been suggested that the loss of ALRs could be part of an adaptation during the 
evolution of flight (17). While this hypothesis is of interest, it also possible that the loss of 
ALRs in bats may reveal an evolutionary arms race that occurred between 
pathogens and this host. Bats are well-known reservoir of numerous pathogens including 
DNA viruses. It is possible that the loss of ALRs in these organisms is the result of a co-
evolution between bat innate immune sensors and a pathogen. While the mechanisms that 
triggered the loss of ALRs in bats are still unclear, it is likely that the loss of ALRs 
 7 
facilitates evasion of host immune responses by pathogens, explaining how these 
organisms became suitable hosts of many viruses and other disease agents.  
 
2.3 AIM2 is induced by type I interferon  
Using subtractive cDNA selection, AIM2 (that refers to Absent In Melanoma 2) was 
identified as a gene that was differentially expressed in a model of melanoma (18). While 
the function of this protein was unknown at the time, hints on its function emerged from 
studies that characterized its localization and pattern of expression.  AIM2 is localized 
mostly within the cytoplasm of cells, suggesting that it was likely not involved in directly 
regulating transcriptional processes (19). Expression studies showed that, at basal, AIM2 
expression is mostly detected in the spleen, in small intestine and in peripheral blood (12). 
However AIM2 expression can rapidly be induced. In fact, most ALRs expression is up-
regulated upon treatment that promote type I IFN. This observation defined early research 
on this family and linked ALRs proteins with inflammation and immunity (20-22). Studies 
in mice confirmed that most ALRs are inducible by type I IFN signaling (13).  
Interferons are important mediators of host defenses against invading bacteria and viruses 
and can also contribute to autoinflammation. Type I IFN are produced by PRR upon 
detection of self-molecules or microbial-derived ligands. For example, RIG-I detects 
microbial RNAs and possibly endogenous RNAs (23). The cGAS-STING pathway triggers 
IFN-b production in response to a variety of DNA originating form bacterial, viral, 
parasitic, or self-origins. In response to DNA, the cGAMP synthase (cGAS) produces 
Cyclic-GMP-AMP (cGAMP). This molecule, then, directly interacts with STING leading 
to its activation (24).  In addition, interferons can cooperate with inflammasomes to 
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orchestrate immune responses (25). While inflammasome engagement per se does not 
require transcriptional events, several inflammasomes such as NLRP3 and AIM2 require 
an initial pro-inflammatory signal to promote the expression of inflammasome platforms 
and substrates. This priming phase, also referred to as “signal 1”, is mostly mediated by 
NF-kB transcriptional activation for NLRP3 and type I IFN induction for AIM2 (26). 
Inflammasome activation by AIM2 therefore rely or is amplified by the activation of a 
Type I interferons, a response that is typical of viral infections. It is worth noting that 
cytosolic DNA can trigger both signal 1 for AIM2 via cGAS-STING and signal 2 that leads 
to the post-translational assembly of the AIM2 inflammasome, further demonstrating that 
cytosolic DNA engages multiple parallel pathways that cooperate to maximize 
inflammatory responses. This cooperation is also exemplified by the role of several players 
involved in inflammasome activation. For example, the interferon-inducible protein, 
IRGB10 is required for activation of the DNA-sensing AIM2 inflammasome upon 
infection with Francisella novicida and contributes to the caspase-11 and NLRP3 
inflammasome upon infections Gram-negative bacteria (27). 
 
3. AIM2 ACTIVATION LEADS TO INFLAMMASOME ASSEMLY  
3.1 Inflammasomes are caspase-activating machines  
Inflammasomes are high-molecular weight cellular complexes that, by definition, assemble 
to recruit and activate inflammatory caspases (28). Inflammatory caspases namely human 
and mouse caspase-1, human caspase-4 and caspase-5 and mouse caspase-11, are cysteine-
aspartic proteases that are characterized in mammals by the presence of a caspase 
recruitment domain (CARD) at the N-terminus and a C-terminal portion that is typical of 
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caspases. The modular structure of inflammatory caspases resemble that of apoptotic 
initiator caspases. These enzymes are synthesized as inactive zymogens (pro-caspases) that 
can be swiftly activated following an appropriate stimulus. This activation is post-
translational and required proximity induced dimerization of the pro-caspases, leading to 
the stimulation of the enzymatic activity by the caspase dimer and the subsequent 
processing of the pro-caspase into a small subunit and large subunit (29). Apoptosome 
formation is among the best-characterized mechanisms mediating activation of initiator 
caspases. A clear delineation of the sequential events required for apoptosome formation 
have been described (30). At the initiation stages of apoptosis, mitochondrial cytochrome 
c is released into the cytosol. Then, cytochrome c binds apoptotic protease activating 
factor-1 (Apaf-1), triggering a conformational change that results in its oligomerization and 
recruitment of caspase-9. The resulting apoptosome facilitates the autocatalytic cleavage 
of the pro-caspase-9 that remains active and associated with the apoptosome (31).  Studies 
on the apoptosome inspired the experiments that lead to the initial discovery of the 
inflammasome. The inflammasome was first detected in a cell-free assay that was designed 
to study the apoptosome complex (28). The term inflammasome was coined to 
acknowledge the apparent similarity of the complex with the apoptosome and to indicate 
that its main function is the activation of inflammatory caspases such as caspase-1. In 
contrast to the apoptosome that is a well-conserved and unique complex, inflammasomes 
can be assembled by several initiator PRRs that can detect different stimuli. However most 
classical inflammasomes share common mechanisms of activation that were initially 
described in the context of NLRP3 inflammasome activation (32, 33).  
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The NLRP3 inflammasome is formed by the recruitment of the adaptor ASC through PYD-
PYD interactions and subsequent recruitment of caspase-1 via the caspase CARD and the 
CARD of ASC. As a result of the initial ASC oligomerization within the inflammasome, 
ASC can further auto-assemble into large filament structures. This process is referred to as 
“prion-like” polymerization. It dramatically amplifies the inflammasome assembly by 
virtually engaging all ASC molecules into one active molecular structure (34). This 
amplification was described for several signalling pathways that use the death fold (such 
as PYD and CARD) as a recruitment and activation domain. Most of these pathways are 
involved in innate immunity and may have evolved to enable a robust and rapid response 
to an insult (35). Prionisation of the signal has been observed for all ASC-containing 
inflammasome tested so far including the AIM2 inflammasome (36).  
Within the AIM2 inflammasome, the PYD of AIM2 drives both filament formation and 
may facilitate ligand binding (37). The AIM2 PYD oligomers orchestrate the filamentous 
structure of the downstream ASC filaments and subsequent AIM2 inflammasome signaling 
(Figure 1). These filaments form a multitude of caspase-1 activation sites, thereby 
amplifying inflammasome signaling (38). 
 
3.2 Inflammasomes mediated IL-1b and IL-18 production. 
In contrast to apoptotic caspases that have multiple substrates described so far, 
inflammatory caspases have only a few bona fide substrates that have been characterized. 
Inflammatory caspases are termed 'inflammatory' because the main caspase-1 substrates 
identified to date are proIL-1b and proIL-18, two structurally related cytokines that 
contribute to inflammation. IL-1b is a pleiotropic cytokine that acts on multiple cell types 
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to drive inflammatory responses (39). At the systemic level, IL-1b elicits a fever response 
by acting directly on the hypothalamic temperature regulation centre (40). IL-1β is mostly 
produced by cells of the innate immune system and signals by binding to the IL1 receptor 
type 1 (IL1R1) complex. Once engaged, IL1R1 and its co-receptor IL1 receptor accessory 
protein (IL1RAP) recruit signalling adaptor and effector proteins that will trigger the 
production of inflammatory mediators. Similarly, IL-18 signals by engaging the IL-18R 
complex. Proteins such as MyD88 and IRAK4 are key components used by the proximal 
signalling complexes triggered by the IL-1R the IL-18R pathways as well as the TLRs (41). 
This similarity clearly indicates that the inflammasome-IL-1b/IL-18 system and the TLRs 
engage analogous response at the molecular level and suggest these innate pathways are 
variations that originate from a common ancestor pathway.  
3.3 Inflammasomes mediated Pyroptosis 
Another important target of inflammasome proteolytic activity leads to the activation of a 
pro-inflammatory type of cell death termed pyroptosis (42, 43). Pyroptosis was first 
observed in macrophages infected with intracellular bacteria (44, 45). In infected 
macrophages, caspase-1 deficiency impaired pyroptosis. In addition to caspase-1, other 
pro-inflammatory caspases such as caspase-11 have robust pyroptosis-inducing properties. 
Inflammatory caspases-mediated cell death, differs from caspases-mediated apoptosis in 
that it disrupts membranes in a way that triggers the release of the cytosolic content into 
the extracellular milieu. This leads to the exposure of danger signals and several 
proinflammatory mediators that can initiate or amplify immune responses. By disrupting 
membrane boundaries, pyroptosis has also been proposed to contribute to the passive 
release of leaderless cytokines such as mature IL-1b  (46).  
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AIM2 mediated pyroptosis has been shown to be caspase-1-dependent. However, in 
caspase-1 deficient mice, AIM2 activation promotes the activation of the proapoptotic 
caspase-8, leading to a caspase-1 independent cell death, by a process that resemble 
apoptosis (47). It is therefore likely that in the context of caspase-1 inhibition; 
inflammasome platform can engage alternative routes to trigger cell death, similarly to 
apoptosis processes that can elicit necroptosis in absence of caspases  (48, 49). 
Recently, a family of proteins named Gasdermins have emerged as key mediators of 
inflammatory caspases-mediated cells death (50-52). Caspase-1 or caspase-11 have been 
shown to cleave Gasdermin D (GSDMD). This releases the N-terminal portion of the 
Gasdermin that then polymerizes at the plasma membrane forming cytotoxic pores. These 
pores disrupt cellular integrity and result in cell death with typical feature of pyroptosis 
(Figure 2).  
 
4. AIM2 DETECTION OF DNA  
Transfection of host, bacterial and viral DNA, beside its effects on the transcriptional 
activation type-I IFN, has been shown to initiate a cascade leading to the proteolytic 
maturation of IL-1b. These DNA molecules relied on an ASC-dependent but NLRP3-
independent inflammasome (53). The use of an orthogonal proteomic-genomic screen in 
mouse cell lines, identified AIM2 as the main cytoplasmic DNA sensor promoting 
inflammasome assembly. A proteomic screen for DNA-binding proteins that interacted 
with IFN-b-stimulating dsDNA was coupled to a genomic screen for IFN-b regulated 
genes. The results of these screens were crossed and several ALR proteins were identified 
as candidates of interest. Among them, AIM2 was found to trigger an inflammasome while 
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co-expressed with ASC, caspase-1 and IL-1b (9). Other studies showed that the AIM2 
PYD domain was necessary to interact with ASC in order to nucleate an inflammasome 
(10, 11). These studies demonstrated that AIM2 is the cytosolic sensor for dsDNA that, 
upon engagement, promotes the activation of caspase-1 in mouse BMDMs. In contrast, the 
decoy ALR protein p202 was found to repress dsDNA activation of caspase-1 (54). AIM2 
cytosolic subcellular localization and its ability to detect cytosolic DNA make of this 
protein a bona fide cytosolic innate immune sensor. 
 
4.1 DNA sensors 
The ability of the immune system to respond to DNA was first discovered with the study 
of the endosomal toll-like receptor 9 (TLR9). TLR9 binds CpG DNA from bacteria and 
triggers innate immune responses via the MyD88 adaptor (55). The DEAD/H-box helicases 
DHX9 and DHX36 were also found to be MyD88-dependent DNA sensors that activate 
NF-kB and IRF7 in plasmacytoid dendritic cells (56). DNA-dependent protein kinase 
(DNA-PK), a protein complex was found to detect cytosolic DNA via the Ku70 subunit 
leading to the activation of type III IFNs (57). Several DNA sensors have been described 
to elicit a strong type I IFN response signal through the activation of the adaptor protein 
STING (58). STING is a master regulator of type I IFN innate immunity triggered by 
cytosolic DNA(59). It centralizes the signal from the DNA sensors cGAS(60, 61), 
DDX41(62), DNA-PK(63), MRE11(64), DAI/ZBP1 (65, 66) and possibly the ALR protein 
IFI16 and its mouse ortholog p204(67). These pathways trigger the STING-TBK1-IRF3/7 
axis and subsequent transcription of type I IFNs (58).  
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Compared to other DNA sensors AIM2 is specialized in inflammasome assembly rather 
than promoting type I IFN responses.   
4.2 AIM2 directly binds DNA molecules  
Biochemical studies indicated that AIM2 binds DNA directly and that the HIN domain was 
sufficient for this interaction (11). Consitently, mutations within the HIN domain impaired 
AIM2 ability to bind immunostimulatory dsDNA immobilized on resin (9). ALRs were 
described to bind dsDNA of virtually any origin including microbial, host or synthetic 
molecules that vary in sequence and GC content (9-11, 54, 67). The lack of apparent 
specificity of the HIN-DNA interactions is supported by the nature of the HIN-DNA 
interactions (68, 69). Sensitivity of HIN-DNA interaction to ionic strength suggested the 
involvemnt of electrostatic attractions (68). Moreover, crystallographic analyses of DNA 
interaction with AIM2 and IFI16 revealed that the hydrophobic pocket of the HIN binds 
both strands of DNA on the sugar-phosphate backbone across major and minor grooves 
(68, 69). In absence of DNA ALRs are in an autoinhibited state with PYD and HIN 
domains. This suggests a machanisms of AIM2 activation in which binding of DNA to the 
HIN domain releases the PYD from its interaction with the HIN domain, thereby promoting 
PYD-PYD interaction with ASC and inflammasome assembly (70). 
4.3 AIM2 detects DNA from pathogens 
During infections with intracellular pathogens, microbial DNA can be released in the 
cytosol.  AIM2 function as a DNA sensor has been extensively described in the context of 
several microbes and pathogens (71), further highlighting the role of this protein in innate 
immunity.  
AIM2 detects bacterial DNA 
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Francisella tularensis (72-74) and Lysteria monocytogenes (73, 75) were the first live 
bacteria identified to engage the AIM2 inflammasome. In particular F. tularensis is a poor 
activator of innate immune pathways and function mostly by engaging TLR2 and the AIM2 
inflammasome. In contrast, Lysteria monocytogenes activates several inflammasomes and 
AIM2 contribution is best detected in macrophages deficient for NLRC4 and NLRP3 (75). 
So far, many bacterial species have been found to activate AIM2 including F. tularensis, 
L. monocytogenes, Streptococcus pneumoniae, species of Mycobaterium as well as 
Legionella pneumophila and Staphylococcus aureus. These observations have been 
extensively reviewed recently (71).  
In order to be detected by AIM2 bacteria have the necessity to escape the vacuole and 
undergo bacteriolysis, leading to the exposure of bacterial DNA in the cytosol. Via 
activation of autocrine type I IFN signaling, Francisella subspecies novicida (F. novicida) 
induces the expression the transcription factor IRF1. IRF1 in turn controls the expression 
of IFN-inducible GTPases tremed guanylate-binding proteins (GBPs) in an autocrine 
manner. GBP2 and GBP5 associate with F. novicida present in the cytoplasm and trigger 
bacteriolysis (76, 77). GBP2 and 5 cannot rescue inflamamsome activation in type I IFN 
receptor-deficient macrophages (76, 77) indicating that additional IFN-induced proteins 
act in collaboration with GBP2 and GBP5 to drive bacterial lysis. Indeed, the IFN-inducible 
protein IRGB10 has recently been described as a crucial partner for GBPs for killing of 
intracellular bacteria (27). IRGB10 colocalizes with GBPs at the membrane of intracellular 
bacteria that escaped in the cytosol. It is present to bacterial membrane sites where 
membrane integrity is lost. Moreover, sequence analysis of IRGB10 indicates the presence 
of amphipathic helices and myristoylation motifs that may account for its membrane 
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disrupting properties. This however needs to be experimentally characterized. Irgb10-/- 
mice, similar GBPs-, AIM2- and Caspase-1-deficent mice, are less resistant to F. novicida 
infection, exhibit higher bacterial loads and less IL-18 production than control mice. 
Moreover, IRGB10 was not only shown to favor the release of bacterial DNA in the cytosol 
to fully activate AIM2 inflammasome, it also favors the release of LPS from bacterial 
membrane to activate Caspase-11 and possibly other inflammasomes (27). 
AIM2 detection of Viruses 
Given its abilities to recognize non-specifically dsDNA structures, one may picture AIM2 
to be a broad sensor of DNA viruses. However, despite the fact that AIM2 can detect viral 
DNA its contribution to viral immunity is still unclear. Mouse cytomegalovirus (MCVM), 
vaccinia virus and human papilliomavirus have been shown to induce AIM2 
inflammasome (11, 73, 77, 78). Mechanism by which viral DNA is liberated and exposed 
to AIM2 in the cytosol is not clearly defined. Viruses have been shown to evade AIM2 
sensing possibly by inhibiting the ability of AIM2 to interact with released DNA. A recent 
study reported that Epstein-Barr virus (EBV) may activate AIM2 in THP1 cells (79). Two 
studies recently showed that influenza virus (IAV), a single stranded RNA virus, could 
trigger the release of endogenous DNA from damaged lung tissue possibly leading to AIM2 
activation (80, 81). One study stated that AIM2 dampened detrimental inflammation in the 
lung microenvironment of mouse infected with IAV and that AIM2-deficient mice had 
exacerbated immune responses to IAV (80). The other study reported that AIM2-deficient 
mice infected with IAV infection had less lung tissue damage and improved survival (80, 
81). While these findings may seem contradictory, they both suggest that AIM2 can detect 
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host-DNA released in the context of viral infections. The physiological role of this 
detection and the discrepancies observed in the model tested await further studies.  
 
4.4 AIM2 detects endogenous self-DNA upon disruption of nuclear envelope integrity  
The nuclear envelope (NE) defines a cellular compartment that isolates the nucleus and its 
content from the cytoplasm. The NE inner and outer membranes are highly dynamic 
structures riddled with proteins that regulate their functions (82). The nuclear lamina is a 
meshwork of proteins lining the inner nuclear membrane, crucial to NE integrity, 
transmission of mechanical forces, chromatin organization and gene transcription (83). 
Hereditary mutations promoting an impairment of lamin A maturation, an essential 
component of the nuclear lamina, cause a family of diseases called laminopathies. These 
diseases have a large variety of clinical symptoms including cardiac muscular dystrophy, 
lipodystrophy, diabetes, and premature aging. 
Pathologies such as laminopathies, viral infections and cancer are characterized by 
transient alterations of NE homeostasis (82, 84). Defects in NE homeostasis may 
materialize as large blebs of herniating DNA and lamina gaps as observed upon infection 
with HIV (85) or as transient nuclear rupture as observed in cultured fibroblasts from 
laminopathy patients (86). Phenotypically resembling laminopathic defects, cancer cells 
also exhibit defaulted lamin A expression with a nuclear morphology exhibiting transient 
nuclear envelope ruptures (87, 88). 
A consequence of transitory loss of nuclear compartmentalization is an exchange of 
materials between nucleus and cytoplasm. This phenomenon was observed during 
spontaneous NE ruptures occurring in laminopathic fibroblasts or in migrating cells forced 
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through microscopic pores or glass capillaries (86, 89). Transient nature of NE ruptures 
without subsequent elimination of damaged cells indicate the presence of NE repair system 
that remained for long not understood (90). However quality control and repair 
mechanisms of ruptured NE have been recently described (91). Notably, innate immune 
and cancer cells were recently shown to involve the ESCRT (endosomal sorting complexes 
required for transport) III system to repair NE after NE ruptures occurring when  cells 
migrates through small pores (89, 92). This suggests a physiological role of these 
processes, for example in the context of cellular migration. 
During NE rupture, transient exposure of nuclear components within the cytosolic 
compartment raises the question of the possible activation of cytosolic DNA sensors. Cells 
forced through tiny pores exhibited cGAS localization at sites of NE ruptures indicating 
that cGAS is binding DNA at these sites (89). Participation of cytosolic innate immune 
receptors in NE-stress and transient membrane rupture was recently confirmed in a model 
of pharmacological perturbation of the nuclear envelope structure (93). Lamin A 
maturation was found to be inhibited by the anti-viral drug nelfinavir, causing pertubations 
in nuclear architecture and transient exchanges of nuclear and cytoplasmic contents. As 
consequence of exposure of nuclear DNA in the cytoplasm, AIM2 and cGAS cytosolic 
DNA sensors were activated (93) (Figure 3). These results further emphasized on a possible 
contribution of stress of the NE and its associated inflammatory pathways to diseases with 
transient NE ruptures, including laminopathies and cancers. Yet the physiological 
relevance of this contribution remains to be investigated. 
 
4.5 AIM2 detects DNA damage within the nucleus  
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Besides its well-described ability to detect dsDNA within the cytosol, AIM2 has been 
recently proposed to detect DNA damage directly within the nucleus (94). In a mouse 
model of subtotal body exposure to ionizing radiation with gastrointestinal toxicity, 
inflammasome-deficient mice were found to be more resistant to irradiation. AIM2 was 
identified as the only inflammasome sensor responsible for resistance to irradiation-
induced intestinal toxicity in this model. Irradiation toxicity was mediated by pyroptosis of 
epithelial intestinal cells. Notably, drugs such as doxorubicin and etoposide that trigger 
DNA double-strand breaks (DSB) also promoted AIM2-mediated cell death. In contrast 
UV irradiation, that mediates single-strand breaks, did not rely on AIM2 to promote 
cytotoxicity. Interestingly AIM2 colocalized with g-H2Ax at sites of DSB in irradiated 
BMDM. Moreover, ASC specks were also identified within the nucleus upon DNA 
damage, indicating that the AIM2 inflammasome can assemble and function within nuclei. 
Whether nuclear inflammasomes have different proteolytic substrates than cytosolic 
inflammasome is a possibility that needs to be investigated. While IL-1b localization 
within the nucleus was detected before (95), the pyroptosis-mediating factor Gasdermin D 
was reported to be exclusively cytosolic (96). It is possible that Gasdermin D localizes in 
the nucleus of epithelial cells undergoing DNA damage, alternatively AIM2 could uses a 
different pathway to promote pyroptotic cell death upon DNA damage. 
4.6 AIM2 detects released self-DNA secreted by exosomes 
Besides sensing cell intrinsic dsDNA, AIM2 in macrophages and dendritic cells has 
recently been proposed to sense self-DNA delivered by exosomes produced by intestinal 
epithelial cells exposed to chemotherapeutic agents (97). In colon cancer patients treated 
with the cytotoxic chemotherapeutic agent CPT-11 (Irinotecan), the severity of side-effects 
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such as diarrhea correlated with serum levels of dsDNA (97).  Moreover in a mouse 
xenograft model in which MC-38 murine colon carcinoma cells were injected prior to 
Irinotecan administration to mice, small intestine shortening and dsDNA increase in 
peritoneal lavage was observed. Released dsDNA could induce IL-1b maturation and 
inflammasome assembly when transfected in BMDM and BMDCs. This activation was 
abrogated in AIM2-deficient BMDM and BMDC (97). Further studies showed that the 
main source of dsDNA released by cells treated with an active form of CPT-11 was present 
within exosomes. These DNA-loaded exosomes were taken up by BMDM. In mice, 
chemical inhibition of exosomes generation as well as AIM2-deficiency reduced  CPT-11 
mediated intestinal damages caused by inflammasome activation. Exosomes may therefore 
act as vehicle for the delivery of inflammatory DNA, possibly protecting such DNA from 
degradation by extracellular nucleases. 
 
4.7 AIM2 detects DNA vaccines 
The ability of AIM2 to sense dsDNA from extrinsic origin makes it a good candidate as 
DNA vaccines sensor. In vitro, IL-1b production as well as pyroptosis were found to be 
mediated by AIM2 in BMDM transfected with a DNA vaccine. Moreover, vaccine 
immunogenicity was greatly impaired in AIM2 deficient mice as reflected by decreased 
antigen-specific IgG, antigen-specific splenic B cells and IFN-g-secreting T cells. One 
notable point is that in this model, immunogenicity did not depend on IL-1 and IL-18 
signaling since IL-1R- and IL-18R-deficient mice mounted normal responses. 
Interestingly, AIM2 expression was reported to be required in both hematopoietic and 
nonhematopoeitic lineages in order to mount a full response to DNA vaccine (98). The 
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mechanisms and cell types involved remain to be determined. AIM2 deficiency decreased 
type I IFN production in AIM2-deficient mice treated with DNA vaccine.  This observation 
is puzzling and needs to be further investigated. The cGAS/STING pathway has been 
described to significantly contribute to DNA vaccine-mediated immunogenicity (59, 99). 
However, AIM2 inflammasome activation has been reported to antagonize the STING 
pathway (100). This antagonism relies on cleavage of cGAS by caspase-1(101). It is 
therefore possible that the regulation of type I interferon and the activation of the AIM2 
inflammasome occurs at a different time or in a different cell type in the course of DNA 
vaccination.  
Because of its ability to detect DNA vaccines, increased AIM2 expression was considered 
as an attractive strategy to boost DNA vaccination protocols. Three recent studies showed 
that immunization of mice against coxsackie virus B3 (CVB3) using AIM2 as a mucosal 
adjuvant had beneficial effects. Indeed compared to mice immunized with CVB3-specific 
chitosan-pVP1, co-immunization of mice with CVB3-chitosan-pVP1 and chitosan-pAIM2 
conferred better resistance to CVB3-induced myocarditits, increased secretory IgA (102), 
increased CVB3-specific T cells responses (103) and increased counts of CD8+ memory T 
cells (104). 
 
5. REGULATION OF AIM2   
Inappropriate or chronic activation of inflammasomes can lead to diseases displaying 
features of autoinflammation (105).  Regulation of the engagement, the intensity and the 
duration of the response is therefore critical to optimize the reaction while minimizing 
possible side effects of inflammation. While complete understanding of the overall 
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circuitry of inflammasomes regulation is still missing, a few mechanisms impacting AIM2 
activity have been described.  
5.1 Regulation of ligand availability  
Among the strategies that regulate aberrant engagement of DNA sensors such as AIM2, 
organisms have developed mechanisms to compartmentalize DNA and to degrade it when 
mislocalized. This process limits inflammation triggered by apoptotic cells, and reverse-
transcribed DNA from endogenous retro-elements (106, 107). The physiological relevance 
of these mechanisms is exemplified by the fact that deficiencies in nucleases, such as 
DNase II or Trex1, leads to an accumulation of self-DNA that ultimately reaches the 
cytosol where it drives autoinflammatory diseases.  
Certain DNA sequences such as the TTAGGG repeat, regularly found in mammalian 
telomeric DNA, have been shown to display anti-inflammatory activities. Synthetic 
oligodeoxynucleotides with this sequence have been shown to inhibit AIM2 
inflammasome activation (108), indicating that specific sequence may interfere with ALRs 
activations. It is possible that these sequences compete for AIM2 binding thereby blocking 
the recognition of pro-inflammatory DNA sequences. Whether similar sequences from 
endogenous sources or from pathogens can efficiently regulate AIM2, is an interesting 
hypothesis that has not been demonstrated yet.  
 
5.2 Regulation AIM2 by encoded decoy proteins  
Several proteins have been proposed to interfere with the assembly of inflammasomes. 
Decoy proteins encoding PYD or CARD only domains are believed to inhibit 
inflammasome assembly by interfering with PYD-PYD or CARD-CARD homotypic 
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interactions and thereby blocking the recruitment of adaptor and effector proteins to the 
complex (109) (Figure 4). Similar to the repertoire of ALRs and NLRPs, PYD-only 
regulators (POPs) and CARD-only regulators (COPs) are poorly conserved in mammals.  
In humans, three POPs have been identified whiles two predicted POPs sequences are 
present in the mouse genome. Interestingly these human and mouse POPs share weak 
homology and are not orthologs making their studies in animal models challenging. Initial 
evidences indicating that POPs negatively regulate inflammasomes came from the 
identification of viral POPs. M13L a poxvirus-encoded POP was shown to interact with 
ASC to inhibit inflammasome engagement (110). Human POP3 was identified to bind 
AIM2. ASC and POP3 therefore compete for interaction with AIM2 thereby dampening 
inflammasome activation (111). Mice engineered to constitutively express human POP3 
within macrophages have impaired AIM2-activation and defective ability to handle viral 
DNA–induced host defense in vivo (111). This phenotype resembles the phenotype 
observed in AIM2 deficient animals (73), and clearly indicates that these proteins can 
impair AIM2 activation. However, in this model, POP3 expression was artificially 
enforced with a strong promoter. Whether POP3 is induced in physiological conditions, 
and whether it regulates inflammasomes in human, remains to be demonstrated.  
Three COPs have been identified; these proteins are all encoded within the caspase-1 locus 
in human and are absent from the mouse genome. They are all very homologous to the 
caspase-1 CARD and are believed to be the result of recent duplication of the caspase-1 
gene (109, 112). COPs all are predicted to function as caspase-1 decoy proteins that that 
blocks the recruitment of caspase-1 to inflammasomes. However the physiological 
relevance of these putative regulators is still uncharacterized.  
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Other decoy proteins in the pathway have been described within the ALR family. In mice, 
the ALR p202 lacks the PYD domain and has been shown to inhibit AIM2 activation (54). 
Mouse p202 harbors two HIN domains, one has been shown to interact with dsDNA while 
the other one has affinity for AIM2 HIN domain (113). It is possible that p202 functions 
by competing for DNA and therefore may block several innate immune sensors of cytosolic 
DNA. However, p202 has little effect on the activation of type I IFN by the cGAS-STING 
pathway suggesting that it may directly impact AIM2. This was confirmed by structural 
studies that demonstrated the p202 through its second HIN domain interact with AIM2 to 
prevent its oligomerization and subsequent recruitment of caspase-1 (113, 114). 
 
5.3 Other regulators of AIM2  
Beyond regulators that impact ligand accessibility and impair the assembly of 
inflammasomes, AIM2 protein levels can be directly regulated. The tripartite motif 11 
(TRIM11) was reported to be a key negative regulator of the AIM2 inflammasome. Upon 
activation, TRIM11 interacts with AIM2 leading to the recruitment of the autophagic cargo 
receptor p62. The recruitment of this machinery to AIM2 leads to AIM2 degradation via 
selective autophagy (115). These findings demonstrate that post-translational 
modifications contribute to inflammasomes regulation and may be key at regulating the 
intensity and duration of the inflammatory responses (116).  
 AIM2 signaling is regulated by pathogens. For example, Mycobacterium tuberculosis 
dampens proinflammatory signals triggered by microbial DNA within infected 
macrophages. Mechanistically the exact nature of this inhibition is still unknown however 
it was proposed to function by affecting Type I IFN (signal 1) as well as AIM2 assembly  
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(signal 2) (117, 118).  This regulatory loop was found to be dependent on the type VII 
secretion system (ESX-1), a system required for the translocation of M. tuberculosis DNA 
into the host cell cytosol. The fact that the same system can also trigger the release of an 
inhibitor of DNA signaling, may indicate that this mechanism has evolve to counteract 
immune response triggered by the exposure of microbial DNA within host cells.  
 
6. AIM2 IN HEALTH AND DISEASE  
6.1 Role in Infectious diseases 
AIM2 role in sensing pathogens has been shown to contribute to infection in several 
models. Francisella tularensis live vaccine strain (LVS) and subspecies novicida, Lysteria 
monocytogenes, Streptococcus pneumoniae, Mycobacterium tuberculosis and bovis, 
Porphyromonas gingivalis, Legionella pneumophila, Staphylococcus aureus,  Brucella 
abortus and Chlamydia muridarum have been shown to rely on this pathway (71). Several 
pathogens developed mechanisms to limit detection by AIM2 further highlighting the role 
of AIM2 in regulating immune responses. F. tularensis subspecies developed strategies to 
resist bacteriolysis through evolution of virulence factors preventing release of microbial 
products such as bacterial wall components or DNA. F. tularensis subspecies ShuS4 is 
more resistant to bacteriolysis induced by mitochondrial ROS (119). Deletion of RipA 
protein (120) or mutation of the lipid flippase MviN (121) in  F. tularensis as well as 
absence of Sdha gene in L. pneumophiliae (122) all increased AIM2 inflammasome 
activation. Remarkably, F. novicida developed a clustered, regularly interspaced, short 
palindromic repeats-CRISPR associated-Cas (CRISPR-Cas) system strengthening 
bacterial envelope and conferring resistance to host sensors AIM2 and TLR2 (123). 
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Recently, components of the type VI secretion system (T6SS) PdpC and PdpD encoded on 
the Francisella pathogenicity island and the chaperone ClpB were shown to be essential 
for phagosome escape of F. tularensis (124). Phagosomal rupture and AIM2 
inflammasome activation depended on T6SS disassembly, which is regulated by ClpB. 
Strains lacking pdpC and pdpD, normally released by T6SS, were also unable to escape 
phagosome and activate AIM2 but their exact function is still not characterized (124). 
Surprisingly, only few DNA viruses have been reported to activate AIM2. Among them 
mouse cytomegalovirus (mCMV) and Vaccinia virus were the first described (73). AIM2, 
cleaved caspase-1 and cleaved IL-1b were detected in the skin lesion of patients infected 
with Human papillomavirus 16 (HPV16) in region where cytosolic DNA of HPV16 could 
also be detected (78). Human primary keratinocytes released IL-1b and IL-18 when 
transfected with HPV16 DNA and silencing of AIM2 greatly reduced this release (78). In 
an ex vivo human APC model, immune-complexed adenovirus was reported to destabilize 
endosomal membrane via the release of protein VI during capsid disassembly promoting 
the release of viral DNA in the cytoplasm of the APC. Viral DNA then activated AIM2 
inflammasome triggering caspase-1 cleavage, IL-1b maturation and GSDMD processing 
(125). This process has not been studied in vivo so far and whether it benefits to host or 
pathogen needs to be investigated. AIM2 was also reported to promote inflammation-
mediated renal damage in patients with Hepatitis B virus-associated glomerulonephritis 
(HBV-GN) (126). AIM2 was detected in glomerular endothelial and mesangial cells of 
patients with HBV-GN and AIM2 silencing in human mesangial cells infected with HBV 
led to decreased expression of IL-1b and IL-18 (126). The direct participation of AIM2 in 
HBV DNA recognition has not been investigated. Despite the well-established 
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participation of AIM2 in the control of mouse CMV, the role of AIM2 in human CMV 
(hCMV) infection is still poorly defined. Yet, recently the hCMV protein pUL83 was 
discovered to interact with human AIM2 and disrupt AIM2 inflammasome activation (127) 
indicating that AIM2 may be regulated by the viral infection.  
AIM2 has also been described to control RNA viruses including  Chikungunya virus 
(CHINKV), West Nile virus (WNV) and Enterovirus A71 (EV-A71) (128, 129). AIM2 and 
caspase-1 genes were highly up-regulated in primary human dermal fibroblasts upon 
infection with CHINKV and WNV. Inflammasome inhibition  reduced release of IL-1b 
and increased viral titers in CHINKV and WNV infected dermal fibroblasts (128). 
Likewise, EV-A71 promoted up regulation of genes encoding for AIM2 inflammasome 
components in SK-N-SH human neural cell line and AIM2 was found highly expressed in 
the central nervous system of patients infected with EV-A71. Down-regulation of AIM2 in 
SK-N-SH cells decreased pyroptosis upon infection with EV-A71 and augmented viral 
replication (129). In contrast AIM2 did not control the replication of Influenza A virus 
(IAV) in murine models (81). However mice lacking AIM2 had reduced lung inflammation 
and injury after (IAV) infection as illustrated by decreased inflammatory cells infiltrate and 
decreases lung tissue damage (81). The mechanisms of sensing of these RNA viruses by 
AIM2 remains obscure and needs to be further characterized. 
A role for AIM2 in fungal infections was also proposed. NLRP3 and AIM2 are both 
necessary and act in concert to confer a proper immune surveillance against Aspergillus 
fumigatus. Indeed, intranasal infection of mice with A. fumigatus led to aggravated lung 
infections in NLRP3 and AIM2 double knockout mice as compared to WT or single 
knockout controls (130).  
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Plasmodium berghei-derived hemozoin and DNA also dually engage the NLRP3 
and AIM2 inflammasomes during malaria. Hemozoin crystals complex with plasmodial 
DNA in infected red blood cells. After phagocytosis of infected red blood cells or CpG 
DNA-coated synthetic hemozoin, DNA is recognized by TLR9 in the endosomal 
compartment of murine macrophages offering a priming and activation signal for 
inflammasomes (131). Hemozoin activates NLRP3 possibly by promoting lysosomal 
rupture involving cathepsins while plasmodial DNA contained in the endosomal 
compartment is released in the cytosol to activate AIM2 (131). Based on these results 
obtained in vitro, AIM2 should play a role in systemic inflammation during malaria 
infection in humans. However, its exact role on the pathophysiology of malaria is still to 
be characterized in vivo.  
The AIM2 inflammasome is also involved in the pathogenesis of leishmaniasis in patients 
infected with Leishmania (V.) braziliensis (132). AIM2 and caspase-1 mRNA have been 
found more expressed in tissue from lesions of mucosal leishamaniasis compared to lesions 
from the less severe cutaneous leishamaniasis. AIM2 expression and number of IL-1b 
positive cells were also higher in lesions of patients poorly responding to therapy (132). 
How host- or protozoan-derived DNA activates AIM2 inflammasome in tegumentary 
leishmania lesions is still unclear.  
Perturbation in the AIM2 pathway has been reported to deregulate the commensal 
microbiota, indicating that he AIM2 inflammasome is a central regulator of intestinal 
homeostasis (133-135). It may contribute to maintain the production of epithelial 
antimicrobial host defense (136), and its deregulation may contribute to disease 
progression in the mucosa of patients with active inflammatory bowel disease (137). 
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6.4 Autoinflammation  
The concept of autoinflammatory diseases was coined to distinguish a set of inflammatory 
autosomal-dominant diseases from self-directed autoimmune diseases (138). 
Autoinflammatory diseases do not have adaptive immune cell involvement, and are believe 
to be caused by hyper-activation of innate immune pathways leading to aberrant 
inflammation (139).  
Deregulation of inflammasome pathways is a common feature in several genetically 
inherited autoinflammatory diseases.  Patients with gain of function mutation in NLRP3 
have constitutively active inflammasome. This lead to persistent IL-1β and IL-18 secretion 
by myeloid cells and subsequent episodes of systemic inflammation.  
Immunotherapies aimed at reducing the amount of circulating IL-1β or at decreasing its 
ability to bind to the IL-1R complex have been proven to be very efficient in these patients 
at decreasing systemic inflammatory symptoms such as fever and skin rashes (140). 
Autoinflammatory diseases can be triggered by the increased presence of inflammasome -
activating signals. Gout is characterized by a powerful inflammatory reaction stimulated 
by the deposition of monosodium urate crystals within joints. These crystals trigger NLRP3 
inflammasome activation in macrophages thereby initiating an IL-1b-dependent 
autoinflammatory reaction (141).  
Similarly, increased amount of self-DNA can initiate autoinflammation by exacerbated 
activation of the DNA sensors pathways including the cGAS-STING pathway and the 
AIM2 inflammasome. This was reported for example in a mouse model of polyarthritis-
like disease caused by DNase II deficiency. In these mice, that show increased release of 
 30 
self-DNA within the cytosol, both the cGAS-STING pathway and the AIM2 
inflammasome pathway have contributed to autoinflammation (142, 143).  
Abundant cytosolic DNA was also observed in keratinocytes in psoriatic lesions. In this 
disease, cytosolic DNA, behave like a “disease-associated molecular pattern” that can elicit 
AIM2 inflammasome leading to IL-1β maturation and the autoinflammation signs 
observed in psoriasis patients (144) 
To date, AIM2 had not been linked to inherited autoinflammatory diseases and no gain-of 
function mutations have been identified within AIM2 gene. This is possibly due to the fact 
that AIM2 oligomerization may rely on DNA binding, which may promote the assembly 
of inflammasomes along the DNA structure (68). This is in contrast to NLR-based 
inflammasome that can oligomerize independently of their ligand.   
 
6.3 Autoimmunity  
In addition to its role in triggering inflammation, self-DNA is also associated with typical 
autoimmune diseases. ALRs and AIM2 have been implicated in systemic lupus 
erythematous (SLE) (145, 146). Systemic lupus erythematosus (SLE) is a chronic 
autoimmune disease that can affect most organs. While this disease is characterized by the 
presence of autoantibodies and therefore classify as an autoimmune disease, it presents also 
autoinflammatory features involving innate immune pathways. Monogenic mutations in 
the DNA nucleases (DNASE1 and DNASE1L3), which function in the rapid clearance of 
DNA from apoptotic cells, drive a monogenic SLE (monoSLE) that is characterized by 
autoinflammation and autoimmunity including positive anti-dsDNA antibodies (147). This 
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indicates that over-activation of innate immune sensors of DNA may trigger an 
autoinflammation that could also contribute to autoimmunity in this disease. 
Deregulation of type I IFN pathways is a hallmark of SLE. In addition, genetic studies in 
mice suggested a role for ALRs in SLE. A polymorphism increasing the expression of ALR 
p202 has been associated with a major lupus-predisposing locus of NZB mice (148). While 
it is possible that ALRs may regulate type I IFN responses and thereby modulate disease 
in SLE, ALRs have been found to have a minor function at directly regulating type I IFN 
responses (149). Because p202 is an inhibitor of AIM2 inflammasome, it is likely that the 
inflammasome system is altered in this model to SLE.  In line with this hypothesis, 
macrophages from NZB mice display altered inflammasome activation upon treatment 
with AIM2 agonists. In addition, these mice have an additional polymorphism within the 
NLRP3 gene that alters its expression and blunt the ability of macrophages to mount an 
NLRP3 inflammasome. While the contribution of p202 and AIM2 in SLE remains debated 
(150-152), it is possible that the imbalance between type I IFN responses and AIM2 
activation in this model contributes to autoimmunity.  
6.4 Cancer  
Tumorigenesis and inflammation are known to be tightly intertwined. Chronic 
inflammation promoted by environment, microbial organisms or microbiota is a major 
driver of cancer (153). NLRs and ALRs have been shown to play both positive and negative 
roles in cancer pathogenesis by regulating immune responses, proliferation, cell death and 
intestine dysbiosis (154). AIM2 was initially discovered as a gene absent in human 
melanoma cell line UACC-903 as reflected by the acronym absent in melanoma gene #2 
(AIM2).  AIM2 was found overexpressed following reversion of the tumorigenic 
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phenotype by introduction of human chromosome 6 in UACC-903. Downregulation of 
AIM2 protein expression was shown to play an important role in colorectal cancers (155) 
that display mutations in AIM2 gene (156), silencing by DNA hypermethylation (157) and 
specific decreased tumor tissue expression (158). Similarly, prostate cancer cells also show 
decreased AIM2 expression compared to cells from healthy prostate and begnin prostate 
hyperplasia samples (159). Two studies reported recently the loss of AIM2 expression in 
hepatocellular carcinoma (HCC). In liver samples from patients with HCC, AIM2 
expression was decreased in cancer tissue compared to corresponding non-cancerous 
samples. Moreover, AIM2 expression was negatively correlated with tumor volume, grade 
and metastatic progression (160, 161). In liver, hepatitis B virus X protein (HBx) has been 
proposed to contribute to the downregulation of AIM2 expression both at the transcription 
and protein levels. Indeed, HCC patients that are HBV positive show lower AIM2 
expression levels compared to HCC HBV-negative patients (161). Reconstitution of HCC 
cell lines with AIM2 diminished their proliferation and invasiveness while further 
decreasing the expression of AIM2 augmented signs of disease (160, 161). In this cancer 
type the AIM2 inflammasome was proposed to negatively impact the mTOR-S6K1 
pathway. Reconstitution of AIM2 expression in HCC cell lines had an inhibitory effect on 
mTOR and S6K1 phosphorylation that was reversed by caspase-1 inhibition. 
Reconstitution of AIM2 expression also impaired tumor growth in a HCC xenograft model 
(160). In a different mouse model of HCC, decreased AIM2 expression led to increased 
number of liver tumors and lung nodules (161). AIM2 silencing increased Fibronectin 1 
(FN1), a factor that could be responsible for the epithelial to mesenchymal transition 
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enabling HCC metastasis (161). Whether AIM2 ability to repress FN1 depends on 
inflammasome assembly has not been investigated so far.  
Recently, two studies characterized the role of AIM2 in a murine model of colitis-
associated cancer chemically induced by azoxymethane (AOM) injection followed by 
dextran sodium sulfate (DSS) treatment (162, 163). One study used the AOM/DSS model 
to demonstrate that AIM2 suppression of colon tumorigenesis was independent of 
inflammasome formation and instead relied on the suppression of the DNA-PK-Akt axis 
(163). Additionally, the sporadic development of colon cancer in ApcMin/- model, was 
aggravated by AIM2 deficiency. Increased Akt phosphorylation in AIM2 deficient tumors 
correlated with bigger tumor load. It was proposed that AIM2 could directly interact with 
DNA-PK, an Akt kinase activated by DNA damage, possibly limiting DNA-PK activation 
and subsequent Akt phosphorylation and cell proliferation (163). The second study showed 
that the inflammasome-independent role for AIM2 in the protection against colon cancer 
was mainly driven by stromal cell expression of AIM2 and not by myeloid cells (162, 163). 
Consistently they observed that AIM2-deficiency increased proliferation in vivo and Akt 
phosphorylation. Colonic epithelial progenitor stem cells purified from AIM2 deficient 
mice were more prone to form larger organoids than control mice. Moreover, aberrant 
activation of the WNT/b-catenin pathway increased proliferation of epithelial stem cells in 
the colonic crypts of AIM2-deficient mice (162).  
Conversely, AIM2 expression was increased in human cutaneous squamous cell carcinoma 
(cSCC) (164). Comparison of AIM2 expression levels between normal human epithelial 
keratinocytes and cSCC cell lines showed higher expression of AIM2 in cSCC cells. AIM2 
expression correlated to the grade of the tumors, being low in normal skin, low to moderate 
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in actinic keratosis (pre-cancer) lesions, moderate to high in primary cSCC tumors and high 
in invasive cSCC tumors. This occurred both in sporadic cSCC and cSCC associated with 
organ transplant (164). Pathway analysis of gene expression profiles after decreasing AIM2 
in cSCC cell lines revealed alterations in pathways controlling cell cycle, proliferation and 
invasiveness. In vivo, decreasing AIM2 expression in human cSCC cells prior to xenograft 
transplantation in SCID mice promoted a reduction of tumor volume, cell proliferation and 
tumor vascularization (164). Of note, the implication of inflammasome assembly in this 
tumor type has not been investigated yet. Other cancers, associated with viral infections, 
such as Epstein-Barr virus (165) or human papillomavirus (166) also exhibited increased 
AIM2 expression. Altogether these studies demonstrate that AIM2 has a key role in 
regulating tumorigenesis, however the mechanisms involved are poorly understood. 
Importantly it appears that at least some of AIM2 functions during tumorigenesis may not 
rely on the assembly of typical inflammasome platforms.  
 
7 CONCLUSIONS AND PERSPECTIVES  
Inflammasomes are key players in the regulation of cellular stress and immune responses. 
The molecular mechanisms governing initiation and assembly of inflammasomes are still 
poorly understood. While most inflammasomes described so far respond to well-
characterized stimuli, how the signal is transmitted to the scaffolding receptor is mostly 
unknown.  The ligands of most inflammasome complexes are still unclear or poorly 
characterized except for AIM2 that is a bona fide DNA detector. DNA is ubiquitous; 
therefore, AIM2 can be considered a sensor of pathogens when it detects microbial DNA. 
However when it detects mislocalized self-DNA, it functions as a sensor of altered self. It 
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behaves as a guardian of cellular integrity that can responds to perturbations and loss of 
cellular homeostasis such as, for example, disruption of nuclear envelope integrity. This 
raises several questions that remain to be elucidated.  Recent studies have demonstrated 
that AIM2 detects self-DNA. However, how this detection is regulated to achieve 
specificity in order to detect pathogen and stress conditions and how this contributes to 
immune responses is still unclear. During mitosis, the phosphorylation of nuclear lamins 
causes the nuclear envelope to disintegrate into small membrane vesicles. The disruption 
of the nuclear compartment exposes chromosomal DNA to cytosolic components. Whether 
DNA packed within chromosomes can engage AIM2 is debated.  However it is likely that 
during mitosis dsDNA is exposed and mechanisms are in place to avoid aberrant AIM2 
activation. This has been proposed for the NLRP3 inflammasome. NLRP3 activation 
requires the binding of NEK7, a kinase involved in cell cycle. It was hypothesized that 
NEK7 function and regulation during cell cycle, limits its availability to engage NLRP3, 
thereby dampening NLRP3 activation (167). Thus, this mechanism limits NLRP3 
activation during cell cycle and restrict it to cells in interphase. Why NLRP3 activation is 
blocked during cell cycle progression is currently unknown, and NEK7 does not affect 
AIM2 activation. However it is tempting to speculate that similar mechanisms, yet to be 
described, may function as a safeguard to limit aberrant AIM2 activation in cells 
undergoing cell division.  
The function of AIM2 is also highly controlled by regulation of its expression and 
subcellular localization that may vary depending on several factors including the activation 
of other DNA sensors, the overall inflammatory status, and the tissues involved. Moreover 
the contribution of AIM2 regulators such as POP3, p202 and TRIM11 are still poorly 
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understood and need to be evaluated in physiological models (155). It would be important 
to understand the contribution of these regulators to the modulation of the intensity and 
duration of the response as well as their possible role as safeguard mechanisms limiting 
aberrant detection of self-DNA. 
AIM2 has been mostly studied in cells of the immune system or in the context of infection 
and immune deregulation, however its role in other tissues awaits dedidcated studies. 
Evidences suggests, for example that, in neurons, AIM2 may contribute neuronal 
morphology and influence anxiety and memory in mice (115).  
Another important question that is emerging is the contribution of AIM2 to inflammasome 
independent processes. This has been shown mostly in cancer cells, but may also contribute 
to some of the phenotype observed in AIM2 deficient mice.  
It is foreseeable that these questions will uncover new functions of AIM2 and provide a 
better understanding of the mechanisms by which it promotes immunity and contributes to 
diseases, in particular those with signs of autoinflammation and autoimmunity.  
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Figure 1: Activation of the AIM2 inflammasome. AIM2 is composed an N-terminal 
pyrin domain (PYD) and a C-terminal HIN domain. Both domains interact to keep the 
molecule auto-inhibited. Upon binding of dsDNA auto-inhibition is released leading to 
AIM2 oligomerization and the recruitment of the adaptor ASC via PYD-PYD interactions. 
ASC recruitment leads to polymerisation of the ASC protein leading to the formation of 
fibrilar super-structures. Caspase-1 is recruited to the complex via CARD-CARD 
interactions. Its oligomerization on the complex promotes its activity leading to the 
proteolytic maturation of caspase-1 substrates such as the IL-1b precursor (pro-IL-1b) that 
is processed into the biologically active IL-1b.  
Figure	2:	Mechanisms	of	Pyroptosis	
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Assembly of inflammasomes, such as the AIM2 inflammasome triggers the activation of 
caspase-1 that can cleave GSDMD. This results in release of the GSDMD N-terminal 
(Nter) fragment. GSDM-Nter forms large pores in the plasma membrane that result in rapid 
loss of membrane integrity, the release of cellular content, including dangers signals such 
as uric acid, facilitates the release of other caspase-1 substrates such as IL-
1b.                                eventually 
          pyroptotic           . 
 
 
 	
Figure	 3:	 AIM2	 Inflammasome activation upon destabilization of the nuclear 
envelope 
Perturbations in the maturation of the Lamin A triggers transient alterations of NE 
structures and causes the transient exposure of self-DNA. Released DNA is detected by 
AIM2 leading to the assembly and activation of the AIM2 inflammasome. 
	
 
Figure 4: Regulation of AIM2 by decoy proteins.   
Decoy ALRs do not harbor the PYD and may interfere with AIM2 binding to DNA. These 
regulators may also impair AIM2 oligomerization. POPs are decoy ASC proteins that have 
only one PYD domain and are believed do inhibit PYD-PYD interactions between ASC 
and AIM2. They may function by interacting with AIM2, however some POPs may bind 
ASC and block its recruitment to the inflammasome scaffold. Decoy Caspase-1 (COPs) do 
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not have the caspase domain and are believed to inhibit caspase-1 recruitment to the 
Inflammasome by blocking CARD-CARD interactions.  
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